T505U227

Contact a representative

<h2>Indications, Safety, and Warnings</h2> <h3>Indications for use </h3> <p>These valves are for patients who require replacement of their native or prosthetic aortic and/or mitral valves.</p> <h3>Contraindications </h3> <p>None known. </p> <h3>Warnings, precautions, adverse events </h3> <p>Accelerated deterioration due to calcific degeneration of bioprosthesis may occur in children, adolescents, young adults, and patients with altered calcium metabolism (e.g., chronic renal failure, hyperparathyroidism). </p> <p>Adverse events potentially associated with the use of bioprosthetic heart valves include angina, cardiac arrhythmia, cardiac dysrhythmias, endocarditis, heart failure, hemolysis, hemolytic anemia, hemorrhage (anticoagulant/antiplatelet related), leak (transvalvular or paravalvular), myocardial infarction nonstructural dysfunction (obstructive pannus ingrowth, suture dehiscence, inappropriate sizing, other), stroke, structural deterioration (calcification, leaflet tear, other) thromboembolism, valve thrombosis. It is possible that these complications could lead to reoperation, explanation, permanent disability, and death.</p> <p>Additional adverse events can include angina, cardiac arrhythmia, cardiac dysrhythmias, death, endocarditis, heart failure, hemolysis, hemolytic anemia, hemorrhage, transvalvular or paravalvular leak, myocardial infarction, nonstructural dysfunction, stroke, structural deterioration, thromboembolism, or valve thrombosis.</p> <p>For additional information, please refer to the instructions for use provided with the product.</p> <p><b>Caution:</b> Federal law (United States) restricts this device to sale by or on the order of a physician.</p> <p>UC202410321 EN</p>

Description

The Hancock™ II valve has stood the test of time. First introduced in the 1980s, it has been tested and studied, and earned the trust of cardiac surgeons around the world. After dozens of years of clinical experience and improvements along the way, Hancock II has demonstrated strong performance and durability in both aortic and mitral valve patients.^1,2

David TE, Armstrong S, Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg. 2010;90(3):775–781.
Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg. 2006;132(3):602−609.

Not what you're looking for?

Find more information, including other available configurations, for Hancock™ II bioprosthesis.

First Name

Last Name

Hospital Or Organization

Job Role

Specialty

Confirm country/region

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

Confirm country/region

Before we get started, what best describes you?

Confirm country/region

Before we get started, what best describes you?

First Name

Last Name

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

COUNTRY

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

Hospital Or Organization

Country

HOSPITAL POSTAL CODE

Job Role

Specialty

Description

Not what you're looking for?

United States

Customer Care Team